May 23, 2013
Otsuka Pharmaceutical and H. Lundbeck A/S of Denmark announced on May 22 that the once-monthly injectable treatment Abilify Maintena (aripiprazole) demonstrated a statistically significant reduction in total psychiatric hospitalization rates for schizophrenia patients previously taking oral antipsychotics who were switched...read more